Unops NO 12 O Pyithu Lane 7 Mile Pharmaceutical Import Profile — Myanmar (DGFT 2022–2026)

Name: Unops NO 12 O Pyithu Lane 7 Mile Pharmaceutical Import Records from India — 2 Products, $950.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unops NO 12 O Pyithu Lane 7 Mile — Pharmaceutical Importer Profile (2026) | 2 Products, $950.0K Trade | TransData Nexus

Unops NO 12 O Pyithu Lane 7 Mile

Pharmaceutical Importer · Myanmar · Tuberculosis Medications Focus · $950.0K Total Trade · DGFT Verified

Unops NO 12 O Pyithu Lane 7 Mile is a pharmaceutical importer based in Myanmar with a total trade value of $950.0K across 2 products in 1 therapeutic categories. Based on 19 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Unops NO 12 O Pyithu Lane 7 Mile sources from 4 verified Indian suppliers, with Lupin Limited accounting for 84.6% of imports.

Unops NO 12 O Pyithu Lane 7 Mile — Import Portfolio & Supplier Network

Unops NO 12 O Pyithu Lane 7 Mile import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Unops NO 12 O Pyithu Lane 7 Mile?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lupin Limited	$450.0K	9	84.6%
Maneesh Pharmaceuticals Limited	$50.0K	4	9.4%
Macleods Pharmaceuticals Limited	$30.2K

What Formulations Does Unops NO 12 O Pyithu Lane 7 Mile Import?

Formulation	Value	Ships
Stop tb cat i+ii kit arifampicin150mg+isoniazid75mg+pyrazinamide400mg+ethambutol275mg6x28t+rifa.150MG+iso.75mg12x28t	$200.0K	4
Stop tb cat i+ii kit arifampicin150mg+isoniazid75mg+pyrazinamide400mg+ethambutol275mg6x28t+	$200.0K	4
Ethambutol tabs BP 400MG Each carton of24x28 tabs 3979	$50.0K	1
4 fdc tablet undpeng/sp/por/frrifampicin 150MG+isoniazid 75MG+pyrazinamide 400MG+ethambutol hcl	$50.0K	1
Zidovudine 50MG/5ML oral solution 100mlbottle net content: 6.8230 kgs zidovudine ps: 1x100ml	$24.3K	1
Zidovudine 50MG/5ML oral solution 240mlbottle net content: 4.8000 kgs zidovudine ps: 1x240ml	$5.9K	1
Omeprazole and lansoprazole: omepraven omeprazole capsules 20 MG pieces - packs of 10 x 1 x 14s - capsules	$1.8K	1
Supp. manufacturing .svizera labs p.limitedeou:b-17 bond rs.36701000/-green card no.21044 dtd.31.07.2020 valid upto	$0	1
Eou lop no: per: 992002 seepz: eou: laii- 76/2002-03/2387 dt. 10.01.2003 valid upto	$0	1
Gst tax document no: slp2324/gis00135	$0	1

Unops NO 12 O Pyithu Lane 7 Mile imports 10 distinct pharmaceutical formulations. Showing top 10 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ethambutol	Tuberculosis Medications	$500.0K	10	0.0%	17
2	Pyrazinamide	Tuberculosis Medications	$450.0K	9	0.0%	15

Unops NO 12 O Pyithu Lane 7 Mile imports 2 pharmaceutical products across 1 categories into Myanmar totaling $950.0K.

Unops NO 12 O Pyithu Lane 7 Mile — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Unops NO 12 O Pyithu Lane 7 Mile is a pharmaceutical importer based in Myanmar, specializing in the procurement of finished pharmaceutical formulations. The company operates from its headquarters at No. 12 (O), Pyithu Lane, 7 Mile, Mayangone Township, Yangon, Myanmar. This location is also associated with the United Nations Office for Project Services (UNOPS) in Myanmar, which manages various health and development projects in the country.

As a pharmaceutical buyer, Unops NO 12 O Pyithu Lane 7 Mile plays a crucial role in Myanmar's healthcare supply chain by importing essential medications. The company's focus on finished formulations indicates a commitment to ensuring the availability of ready-to-use medicines for the local market. This approach aligns with Myanmar's efforts to improve healthcare access and quality for its population.

2Distribution Network

Specific details regarding Unops NO 12 O Pyithu Lane 7 Mile's warehouse locations and logistics capabilities are not publicly available. However, given its association with UNOPS Myanmar, it is likely that the company utilizes established UNOPS infrastructure and logistics networks to facilitate the distribution of pharmaceutical products. UNOPS has a history of managing significant development funds and projects in Myanmar, including those focused on health and rural development.

The company's geographic coverage within Myanmar is not explicitly detailed in the available sources. However, considering the strategic location in Yangon, Myanmar's commercial hub, it is reasonable to infer that Unops NO 12 O Pyithu Lane 7 Mile has access to a wide distribution network, potentially covering urban and rural areas across the country.

3Industry Role

Unops NO 12 O Pyithu Lane 7 Mile functions primarily as a pharmaceutical importer, sourcing finished pharmaceutical formulations from international suppliers, particularly from India. The company's import activities are integral to Myanmar's pharmaceutical supply chain, ensuring the availability of essential medications for the local market. While the company is based in Myanmar, its operations are closely linked with UNOPS Myanmar, which manages various health and development projects in the country.

The company's role as a pharmaceutical importer is critical in addressing the healthcare needs of Myanmar's population. By focusing on finished formulations, Unops NO 12 O Pyithu Lane 7 Mile contributes to the timely and efficient delivery of medications, supporting the overall health infrastructure in Myanmar.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Unops NO 12 O Pyithu Lane 7 Mile

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Unops NO 12 O Pyithu Lane 7 Mile's sourcing strategy exhibits a high degree of concentration, with a total import value of $950,000 USD across 19 shipments, primarily from four Indian suppliers. The top three suppliers are:

Lupin Limited: $450,000 USD (9 shipments, 84.6% of total value)
Macleods Pharmaceuticals Limited: $30,000 USD (2 shipments, 5.7% of total value)
Maneesh Pharmaceuticals Limited: $50,000 USD (4 shipments, 9.4% of total value)

This sourcing pattern indicates a strategic choice to maintain strong relationships with a select group of suppliers, potentially ensuring consistent quality and supply. The significant share held by Lupin Limited suggests a preferred partnership, possibly due to favorable terms or product offerings.

However, the reliance on a limited number of suppliers may pose risks related to supply chain disruptions. Any issues affecting these suppliers could impact Unops NO 12 O Pyithu Lane 7 Mile's ability to meet market demand. Diversifying the supplier base could mitigate such risks and enhance supply chain resilience.

2Supply Chain Resilience

Importing Pharmaceuticals into Myanmar — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Myanmar

1Regulatory Authority & Framework

In Myanmar, the Food and Drug Administration (FDA) operates under the Ministry of Health and Sports, overseeing the regulation of pharmaceutical products. The FDA is responsible for ensuring the safety, efficacy, and quality of drugs imported into the country. Key legislation governing pharmaceutical imports includes the National Drug Law and the Regulation on Highly Controlled Drugs. (fda.gov.mm)

The FDA's regulatory framework encompasses the registration of imported drugs, issuance of import licenses, and enforcement of quality standards. Pharmaceutical companies must comply with these regulations to legally import and distribute drugs within Myanmar. The FDA also monitors and controls the importation of controlled substances to prevent misuse and ensure public health safety. (fda.gov.mm)

2Import Licensing & GMP

To import pharmaceutical products into Myanmar, companies must obtain an import license from the FDA. This process involves submitting an application that includes detailed information about the products, their manufacturers, and compliance with Myanmar's regulatory standards. The FDA evaluates these applications to ensure that imported drugs meet the required safety and efficacy standards. (fda.gov.mm)

Good Manufacturing Practice (GMP) certification is a critical requirement for pharmaceutical imports. The FDA recognizes GMP certifications from reputable international bodies, including the European Medicines Agency (EMA), the UK's Medicines and Healthcare products Regulatory Agency (MHRA), and the U.S. Food and Drug Administration (FDA). Alternatively, manufacturers should have prequalification by the World Health Organization (WHO) or produce drugs of specific relevance to Myanmar. (fda.gov.mm)

Unops NO 12 O Pyithu Lane 7 Mile — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Unops NO 12 O Pyithu Lane 7 Mile's focus on importing tuberculosis medications, specifically ethambutol and pyrazinamide, aligns with Myanmar's public health priorities. Tuberculosis remains a significant health challenge in the country, necessitating a steady supply of effective treatments. The company's import strategy is driven by the high demand for these medications, aiming to support the National Tuberculosis Programme and improve treatment outcomes.

By concentrating on these specific therapeutic areas, Unops NO 12 O Pyithu Lane 7 Mile addresses critical health needs, contributing to the broader efforts to combat infectious diseases in Myanmar. This strategic focus also positions the company as a key player in the pharmaceutical supply chain for tuberculosis treatments.

2Sourcing Profile

Unops NO 12 O Pyithu Lane 7 Mile's sourcing strategy emphasizes the procurement of generic drugs, particularly those used in the treatment of tuberculosis. The company's preference for finished pharmaceutical formulations indicates a focus on ready-to-use products, ensuring timely availability for the Myanmar market. India's well-established pharmaceutical industry, known for its generic drug production, aligns with the company's

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Unops NO 12 O Pyithu Lane 7 Mile

What products does Unops NO 12 O Pyithu Lane 7 Mile import from India?

Unops NO 12 O Pyithu Lane 7 Mile imports 2 pharmaceutical products across 1 categories. Top imports: Ethambutol ($500.0K), Pyrazinamide ($450.0K).

Who supplies pharmaceuticals to Unops NO 12 O Pyithu Lane 7 Mile from India?

Unops NO 12 O Pyithu Lane 7 Mile sources from 4 verified Indian suppliers. The primary supplier is Lupin Limited (84.6% of imports, $450.0K).

What is Unops NO 12 O Pyithu Lane 7 Mile's total pharmaceutical import value?

Unops NO 12 O Pyithu Lane 7 Mile's total pharmaceutical import value from India is $950.0K, based on 19 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Unops NO 12 O Pyithu Lane 7 Mile focus on?

Unops NO 12 O Pyithu Lane 7 Mile imports across 1 categories. The largest: Tuberculosis Medications (100.0%).

Get Full Unops NO 12 O Pyithu Lane 7 Mile Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.